We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

122 hedge funds and large institutions have $532M invested in Array Biopharma Inc in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 41 increasing their positions, 42 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 42

7% less capital invested

Capital invested by funds: $571M → $532M (-$38.6M)

15% less funds holding

Funds holding: 143 → 122 (-21)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

66% less call options, than puts

Call options by funds: $1.61M | Put options by funds: $4.79M

76% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 25

Holders
122
Holders Change
-21
Holders Change %
-14.69%
% of All Funds
3.52%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.12%
New
6
Increased
41
Reduced
42
Closed
25
Calls
$1.61M
Puts
$4.79M
Net Calls
-$3.18M
Net Calls Change
+$526K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$4.89M
2
DM
Deerfield Management
New York
+$4.88M
3
BI
BVF Inc
California
+$4.7M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$4.37M
5
State Street
State Street
Massachusetts
+$3.05M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.77M
2
GC
GMT Capital
Georgia
-$2.52M
3
GC
Guggenheim Capital
Illinois
-$2.42M
4
QF
QVT Financial
New York
-$1.9M
5
Renaissance Technologies
Renaissance Technologies
New York
-$1.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$3.07M +$179K +35,677 +6%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$2.68M +$376K +74,742 +15%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$2.65M +$164K +32,598 +6%
CCI
29
Columbus Circle Investors
$2.27M +$1.18M +235,346 +95%
SCM
30
Suffolk Capital Management
New York
$2.25M +$69.4K +13,800 +3%
CGT
31
Capital Guardian Trust
California
$2.23M – – –
TCIM
32
TIAA CREF Investment Management
New York
$2.21M -$33.8K -6,720 -1%
BG
33
BlackRock Group
United Kingdom
$2.05M – – –
Millennium Management
34
Millennium Management
New York
$1.94M -$2.77M -550,484 -57%
TD Asset Management
35
TD Asset Management
Ontario, Canada
$1.7M +$145K +28,800 +9%
BIM
36
BlackRock Investment Management
Delaware
$1.61M +$26.5K +5,276 +2%
Goldman Sachs
37
Goldman Sachs
New York
$1.61M +$1.56M +311,193 +994%
RPAM
38
Rhenman & Partners Asset Management
Sweden
$1.55M -$155K -30,801 -9%
CNB
39
City National Bank
California
$1.49M +$555K +110,285 +54%
BlackRock
40
BlackRock
New York
$1.48M +$1.62K +322 +0.1%
Charles Schwab
41
Charles Schwab
California
$1.46M +$154K +30,625 +11%
Group One Trading
42
Group One Trading
Illinois
$1.45M +$356K +70,756 +30%
OM
43
Opaleye Management
Massachusetts
$1.43M +$1.53M +305,000 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$1.38M – – –
PAM
45
Panagora Asset Management
Massachusetts
$1.33M -$12.9K -2,561 -0.9%
SONJCPFA
46
State of New Jersey Common Pension Fund A
New Jersey
$1.25M – – –
Allianz Asset Management
47
Allianz Asset Management
Germany
$1.12M -$72.6K -14,429 -6%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$1.05M – – –
ProShare Advisors
49
ProShare Advisors
Maryland
$1.04M +$793K +157,763 +248%
Wells Fargo
50
Wells Fargo
California
$986K +$241K +47,914 +30%
1
2
3 4 5

ARRY Hedge Fund Activity: Q1 2014 in Review

122 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q1 2014, worth a combined $532M — down 6.8% from $571M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ARRY and 6 opened new positions — a net loss of 19 holders — while 42 trimmed existing stakes and 41 added.

The largest buyer was OrbiMed, adding an estimated $4.89M. The largest seller was Millennium Management, cutting an estimated $2.77M.

  • 122 institutional investors held Array Biopharma Inc (ARRY) as of Q1 2014, down from 143 in Q4 2013.
  • Funds reported $532M of Array Biopharma Inc stock for Q1 2014, down 6.8% quarter-over-quarter.
  • 6 funds opened new Array Biopharma Inc positions in Q1 2014 and 25 closed out, a net change of -19 holders.
  • The largest Array Biopharma Inc buyer in Q1 2014 was OrbiMed, an estimated $4.89M added.
  • The largest Array Biopharma Inc seller in Q1 2014 was Millennium Management, an estimated $2.77M sold.

Based on aggregated 13F filings for Q1 2014.